AMPYRA

Ampyra is the market name of Dalfampridine. Ampyra is pronounced as “am-PEER-ah,” as stated by the maker's website in the United States by Acorda.
Responders to AMPYRA Treatment Showed Improvement in Average Walking Speed Compared to their Average Baseline for Up to 2.5 Years in Open-Label Studies Pooled D.
Acorda Therapeutics is feting the decision by the US Food & Drug Administration (FDA) to approve the marketing of Ampyra (dalfampridine), the fi.

Ampyra in WIKIPEDIA